Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Xeris Biopharma Holdings Inc..
Xeris Biopharma Holdings Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Xeris Biopharma Holdings Inc. are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of Xeris Biopharma Holdings Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Xeris Biopharma Holdings Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Xeris Biopharma Holdings Inc. and all latest updates of the company are provided.
The 2025 version of Xeris Biopharma Holdings Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Xeris Biopharma Holdings Inc.- Key Facts
2.2 Xeris Biopharma Holdings Inc.- Geographic Locations
2.3 Xeris Biopharma Holdings Inc.- Subsidiaries and Affiliates
2.4 Xeris Biopharma Holdings Inc.- Business Divisions
2.5 Xeris Biopharma Holdings Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Xeris Biopharma Holdings Inc. Strategic Analysis Review
3.1 Xeris Biopharma Holdings Inc.- Key Strategies
3.2 Xeris Biopharma Holdings Inc.- Company Outlook Statement
3.3 Xeris Biopharma Holdings Inc.- SWOT Analysis
3.3.1 Xeris Biopharma Holdings Inc.- Key Strengths
3.3.2 Xeris Biopharma Holdings Inc.- Key Weaknesses
3.3.3 Xeris Biopharma Holdings Inc.- Potential Opportunities
3.3.4 Xeris Biopharma Holdings Inc.- Potential Threats
3.4 Xeris Biopharma Holdings Inc.- Key Competitors
4. Business Description of the Company
4.1 Xeris Biopharma Holdings Inc.- Business Overview
4.2 Xeris Biopharma Holdings Inc.- Operations by Segment
5 Products and Services Details
5.1 Xeris Biopharma Holdings Inc.- Key Products
5.2 Xeris Biopharma Holdings Inc.- Key Service Areas
5.3 Xeris Biopharma Holdings Inc.- Key Brands
6 Company Developments
6.1 Xeris Biopharma Holdings Inc.- Company History
6.2 Xeris Biopharma Holdings Inc.- Latest Developments
7 Financial Analysis
7.1 Xeris Biopharma Holdings Inc.- Income Statements
7.2 Xeris Biopharma Holdings Inc.- Balance Sheet
7.3 Xeris Biopharma Holdings Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Xeris Biopharma Holdings Inc.- Direct Competitors
8.2 Xeris Biopharma Holdings Inc.- Competitor Financial Ratios comparison
8.3 Xeris Biopharma Holdings Inc.- Competitor Stock Charts Comparison
8.4 Xeris Biopharma Holdings Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
